… assistant professor of medicine at Harvard Medical School and a … significance of the growing treatment options for follicular lymphoma. … in combination with rituximab (Rituxan) and lenalidomide (Revlimid) … [as monotherapy]. This trial was looking at the …

Treatment with the combination of acalabrutinib (Calquence), venetoclax (Venclexta), and rituximab (Rituxan … the Division of Cancer Medicine at The University … . The phase 1b trial evaluated acalabrutinib in combination … withholding of any study drug in 71.4% …

… (CLL) following prior treatment with covalent BTK inhibitors … assistant professor of medicine at Harvard Medical School and an … acquired mutations. What other trials are seeking to combine … , venetoclax, and rituximab [Rituxan]. These were patients who had …

… and Rituxan (rituximab; PVR), researchers have reported. The phase 1b BRUIN trial … researchers reported. Eight patients discontinued treatment early, five in the PV … deaths, one each after discontinuing treatment for progressive disease, after discontinuing …

… has set a Prescription Drug User Fee Act date … trial (NCT02972840) assessing acalabrutinib in combination with bendamustine and rituximab (Rituxan … co-director of Clinical Trials at The University of … the FDA to provide patients this potential new treatment as …

… lymphoma (MCL). The Prescription Drug User Fee Act (PDUFA) … lymphoma. Data from the ECHO trial [NCT02972840] showed [acalabrutinib] … plus bendamustine and rituximab (Rituxan; BR) reduced the risk … approval from the FDA for the treatment of adult patients …

… new drug application for acalabrutinib (Calquence) for the frontline treatment … quarter of 2025. The FDA based its decision on … of bendamustine and rituximab (Rituxan), led to a 27% … . “Data from the ECHO trial showed [acalabrutinib] plus chemoimmunotherapy …

… acalabrutinib, bendamustine, and rituximab (Rituxan; BR; n = 299) … Data from the ECHO trial showed [acalabrutinib] plus … the FDA to provide patients this potential new treatment … ;www.fda.gov/drugs/;resources-information-approved-drugs/fda-grants- …

… MD MODERATOR Professor of Medicine Director, Hematopoietic Stem Cell … photopheresis [ECP], rituximab [Rituxan], and ibrutinib [Imbruvica] still … treatment], even though most if not all of these drugs … of the trials…the [phase 3 iNTEGRATE trial (NCT02959944) …

… ., Ltd. and Chugai Pharmaceutical Co., Ltd. announced 0that … steroid treatment, which is the first-choice drug. Steroid … an investigator-initiated clinical trial targeting patients with childhood … that Rituxan can further contribute to the treatment of …